Regentis Biomaterials (RGNT) Short term Debt (2024 - 2025)
Regentis Biomaterials (RGNT) posted quarterly Short term Debt of $1.2 million for Q4 2025, up 108.9% year-over-year from $573000.0 in Q4 2024, and up 108.9% quarter-over-quarter from $573000.0 in Q4 2024.
Regentis Biomaterials (RGNT) Short term Debt (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has reported Short term Debt for 2 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Short term Debt rose 108.9% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (up 108.9% YoY), while the FY2025 annual figure was $1.2 million, up 108.9% from the prior year.
- Short term Debt advanced to $1.2 million in Q4 2025 per RGNT's latest filing, from $573000.0 in the prior quarter.
- Across five years, Short term Debt topped out at $1.2 million in Q4 2025 and bottomed at $573000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.25 Bn | 129.03 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.47 Bn | 51.61 Bn | 2.32 Bn |
| 3 | Alcon | 35.69 Bn | 34.34 Bn | 1.68 Bn |
| 4 | Resmed | 33.67 Bn | 32.20 Bn | 861.22 Mn |
| 5 | Medline | 29.17 Bn | 26.49 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.06 Bn | 24.62 Bn | 329.20 Mn |
| 7 | Solventum | 15.36 Bn | 14.95 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Regentis Biomaterials | 1.20 Mn | -6.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 573,000.00 |